  | Bellahcene, A., Chaplet, M., Bonjean, K., & Castronovo, V. (2007). Zoledronate inhibits alpha v beta 3 and alpha v beta 5 integrin cell surface expression in endothelial cells. Endothelium: Journal of Endothelial Cell Research, 14 (2), 123-130. doi:10.1080/10623320701347187  Peer Reviewed verified by ORBi |
  | Pincemail, J., Bonjean, K., Cayeux, K., Marot, V., & Renard, A. (2003). The oxidative stress rosette. Free Radical Biology and Medicine, 35 (Suppl. 1), 133. Peer Reviewed verified by ORBi |
 | Wood, J., Bonjean, K., Ruetz, S., Bellahcene, A., Devy, L., Foidart, J.-M., Castronovo, V., & Green, J. R. (September 2002). Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. Journal of Pharmacology and Experimental Therapeutics, 302 (3), 1055-1061. doi:10.1124/jpet.102.035295 Peer Reviewed verified by ORBi |
 | Deroanne, C., Bonjean, K., Servotte, S., Devy, L., Colige, A., Clausse, N., Blacher, S., Verdin, E., Foidart, J.-M., Nusgens, B., & Castronovo, V. (17 January 2002). Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling. Oncogene, 21 (3), 427-436. doi:10.1038/sj.onc.1205108 Peer Reviewed verified by ORBi |
 | Pincemail, J., Bonjean, K., Cayeux, C., Cheramy-Bien, J. P., Defraigne, J.-O., & Feret, J. M. (2002). Oxidative stress status in top soccer players. Free Radical Biology and Medicine, 33 (Suppl. 1), 249-S249. |
 | Bellahcene, A., Bonjean, K., Fohr, B., Fedarko, N. S., Robey, F. A., Young, M. F., Fisher, L. W., & Castronovo, V. (28 April 2000). Bone Sialoprotein Mediates Human Endothelial Cell Attachment and Migration and Promotes Angiogenesis. Circulation Research, 86 (8), 885-91. doi:10.1161/01.RES.86.8.885 Peer Reviewed verified by ORBi |
De Pauw-Gillet, M.-C., Dassonneville, L., Bonjean, K., Colson, P., Houssier, C., Quetin-Leclercq, J., Angenot, L., & Bailly, C. (July 1999). Stimulation of DNA topoisomerase II – mediated DNA clivage by three DNA – intercalating plant alkaloids cryptolepine, matadine and serpentine [Poster presentation]. 2000 Years of Natural Product Research, -Past, Present and Future, Joint Meeting of the ASP, AFERP, GA and PSE, Amsterdam, Netherlands. |
 | Dassonneville, L., Bonjean, K., De Pauw-Gillet, M.-C., Colson, P., Houssier, C., Quetin-Leclercq, J., Angenot, L., & Bailly, C. (1999). Stimulation of topoisomerase II-mediated DNA cleavage by three DNA-intercalating plant alkaloids: cryptolepine, matadine, and serpentine. Biochemistry, 38 (24), 7719-26. doi:10.1021/bi990094t Peer Reviewed verified by ORBi |
Bonjean, K., De Pauw-Gillet, M.-C., Defresne, M.-P., Colson, P., Houssier, C., Dassonneville, L., Bailly, C., GREIMERS, R., Wright, C., Quetin-Leclercq, J., Tits, M., & Angenot, L. (January 1998). Cryptolepine is a potent DNA intercalating agent which inhibits selectively DNA synthesis in B16 melanoma cells cultured in vitro [Poster presentation]. International Symposium Antitumour Products from higher plants, Paris, France. |
 | Bonjean, K., De Pauw-Gillet, M.-C., Defresne, M.-P., Colson, P., Houssier, C., Dassonneville, L., Bailly, C., Greimers, R., Wright, C., Quetin-Leclercq, J., Tits, M., & Angenot, L. (1998). The DNA intercalating alkaloid cryptolepine interferes with topoisomerase II and inhibits primarily DNA synthesis in B16 melanoma cells. Biochemistry, 37 (15), 5136-46. doi:10.1021/bi972927q Peer Reviewed verified by ORBi |
Bonjean, K., De Pauw-Gillet, M.-C., Defresne, M.-P., Colson, P., Houssier, C., Dassonneville, L., Bailly, C., GREIMERS, R., Wright, C., Quetin-Leclercq, J., Tits, M., & Angenot, L. (1997). Cryptolepine is a potent DNA intercalating agent which inhibits selectively DNA synthesis in B16 melanoma cells cultured in vitro [Poster presentation]. New Anticancer Agents, Athène, Greece. |
 | Bonjean, K., De Pauw-Gillet, M.-C., Bassleer, R., Quetin-Leclercq, J., Angenot, L., & Wright, C. (1996). Critical Evaluation of the DNA-methyl Green Assay: Application to Some Indole Alkaloids. Phytotherapy Research, 10, 159-S160. Peer Reviewed verified by ORBi |
 | Bonjean, K., De Pauw-Gillet, M.-C., Quetin-Leclercq, J., Angenot, L., & Bassleer, R. (1996). In Vitro Cytotoxic Activity of Two Potential Anticancer Drugs Isolated from Strychnos: Strychnopentamine and Usambarensine. Anticancer Research, 16 (3A, May-Jun), 1129-37. Peer Reviewed verified by ORBi |
Coucke, P., De Pauw-Gillet, M.-C., Bonjean, K., Siwek, B., Foidart, J.-M., & Bassleer, R. (1994). Characterization and Tumorigenicity of Spheroids Composed of Pigmented or Non Pigmented B16 Melanoma Cells. In Vivo, 8 (3, May-Jun), 333-8. Peer reviewed |
Coucke, P., de Leval, L., Leyh, P., Bonjean, K., Siwek, B., Noël, A., De Pauw-Gillet, M.-C., Paulus, J.-M., Bassleer, R., & Foidart, J.-M. (1992). Influence of laminin or fibroblasts upon colony formation in the mouse by B16 melanoma cell spheroids: a morphometric analysis. In Vivo, 6 (2), 119-24. Peer reviewed |
Siwek, B., Munaut, C., Bonjean, K., Coucke, P., Noël, A., De Pauw-Gillet, M.-C., Foidart, J.-M., & Bassleer, R. (1992). Laminin and 67 Kd Laminin Binding Protein in Mouse B16 Melanoma Cells and 3t3 Fibroblast Spheroids. Anticancer Research, 12 (6B, Nov-Dec), 2011-6. Peer Reviewed verified by ORBi |
Coucke, P., Siwek, B., Munaut, C., De Pauw-Gillet, M.-C., Noël, A., Bonjean, K., Foidart, J.-M., & Bassleer, R. (September 1990). Characterization of tridimensional mixed cultures of mouse B16 melanoma cells and 3T3 fibroblasts [Paper presentation]. 38th annual meeting ETCS, London, United Kingdom. |
Siwek, B., Munaut, C., De Pauw-Gillet, M.-C., Noël, A., Bonjean, K., Coucke, P., FOIDART, J.-M., & Bassleer, R. (1989). Cooperativity between fibroblasts and melanoma cells during invasion [Paper presentation]. 5th Euregio Meeting. |